Acadian Asset Management
LGND icon

Acadian Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Acadian Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-933
Closed -$176K – 2152
2025
Q4 		$176K Buy
+933
New +$179K ﹤0.01% 1548
2024
Q4 		– Sell
-587
Closed -$58K – 1929
2024
Q3 		$58K Buy
+587
New +$59.1K ﹤0.01% 1755
2021
Q1 		– Sell
-146,397
Closed -$9.08M – 2198
2020
Q4 		$9.08M Hold
146,397
– – 0.04% 359
2020
Q3 		$8.71M Sell
146,397
-2,429
-2% -$166K 0.04% 335
2020
Q2 		$10.4M Hold
148,826
– – 0.04% 322
2020
Q1 		$6.75M Hold
148,826
– – 0.04% 331
2019
Q4 		$9.68M Buy
148,826
+20,147
+16% +$1.35M 0.04% 313
2019
Q3 		$7.99M Buy
128,679
+2,698
+2% +$169K 0.03% 381
2019
Q2 		$8.97M Buy
125,981
+92,687
+278% +$6.83M 0.04% 296
2019
Q1 		$2.61M Buy
+33,294
New +$2.52M 0.01% 625
2018
Q4 		– Sell
-45
Closed -$8K – 1775
2018
Q3 		$8K Sell
45
-958
-96% -$144K ﹤0.01% 1572
2018
Q2 		$129K Sell
1,003
-7,017
-87% -$783K ﹤0.01% 1179
2018
Q1 		$826K Buy
+8,020
New +$793K ﹤0.01% 751
2015
Q2 		– Sell
-2,058
Closed -$99K – 1435
2015
Q1 		$99K Buy
+2,058
New +$78.8K ﹤0.01% 1020
2014
Q4 		– Sell
-6,415
Closed -$188K – 1297
2014
Q3 		$188K Buy
+6,415
New +$213K ﹤0.01% 775

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Acadian Asset Management's LGND Position: Q1 2026 in Review

Acadian Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 933 shares — an estimated $176K sold.

Acadian Asset Management first reported a position in LGND in Q3 2014 and held it in 15 quarters. The position peaked at $10.4M in Q2 2020. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Acadian Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 933 Ligand Pharmaceuticals shares in Q1 2026, an estimated $176K.
  • Acadian Asset Management first reported a position in Ligand Pharmaceuticals in Q3 2014 and held it in 15 quarters.
  • Acadian Asset Management's Ligand Pharmaceuticals position peaked at $10.4M in Q2 2020.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.